Abbott’s Volt pulsed field ablation system — for the treatment of atrial fibrillation. The Volt system delivers high-energy electrical pulses to targeted areas of the heart to disrupt abnormal rhythms ...
MedPage Today on MSN
Pulsed field ablation safety issues: Will newer devices clear the stumbling block?
Pulsed field ablation (PFA) has been embraced as a catheter ablation modality with potential to be safer for atrial ...
Patients with atrial fibrillation, or AFib, are at increased risk for stroke.Many of them go on blood thinners, which can cause problems. But there is a relatively new device that is being used ...
Union City Commissioner Douglas Bine filed the suit in November of 2024 after losing his seat in a close election. New report reveals families in southern Ohio living on land at risk of causing cancer ...
Apple's atrial fibrillation (AFib) history feature on Apple Watch has been qualified by the FDA under its Medical Device Development Tools (MDDT) program, the first digital health technology feature ...
Abbott Laboratories' second-generation pulse field ablation device for atrial fibrillation has received European CE Mark approval earlier than expected, the North Chicago-based company said today. The ...
Abbott Laboratories (NYSE:ABT) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 22, Abbott ...
MedStar Heart & Vascular Institute now offers patients with irregular heart rhythm a minimally invasive option to reduce the risk of stroke, as well as enable stopping long-term use of blood thinning ...
CHICAGO, Nov 11 (Reuters) - Johnson & Johnson's ablation device outperformed drug therapy for the heart rhythm disorder atrial fibrillation in a study that will be used to seek U.S. regulatory ...
AMSTERDAM -- Edoxaban (Savaysa) didn't improve outcomes for high-risk patients with subclinical atrial fibrillation (Afib)-like episodes detected by implanted cardiac devices, the NOAH-AFNET 6 trial ...
Heart rhythm is an important vital sign that everyone should be aware of as it is an indicator of overall well-being. When ...
CHICAGO (Reuters) - Johnson & Johnson's ablation device outperformed drug therapy for the heart rhythm disorder atrial fibrillation in a study that will be used to seek U.S. regulatory approval for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback